Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro

American Journal of Pathology

Volumn 154, Issue 3, 1999, Pages 755-765

  Aaltonen, Vesa ^a,b   Boström, Peter J ^a,b   Söderström, Karl Ove ^a   Hirvonen, Outi ^b   Tuukkanen, Juha ^c   Nurmi, Martti ^a   Laato, Matti ^a   Peltonen, Juha ^b,c  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NEUROFIBROMIN; PROTEIN P53; RAS PROTEIN;

ANTIBODY LABELING; ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER GRADING; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NORTHERN BLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE; UROTHELIUM; WESTERN BLOTTING;

EID: 0033035155     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65322-9     Document Type: Article

References (55)

1. Marchuk DA, Saulino AM, Tavakkol R, Swaroop M, Wallace MR, Andersen LB, Mitchell AL, Gutmann DH, Boguski M, Collins FS: cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 1991, 11:931-940
2. Gutmann DH, Wood DL, Collins FS: Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci USA 1991, 88: 9658-9662
3. Barker D, Wright E, Nguyen K, Cannon L, Fain P, Goldgar D, Bishop DT, Carey J, Baty B, Kivlin J, Willard H, Waye JS, Greig G, Leinwand L, Nakamura Y, O'Connel P, Leppert M, Lalouel J-M, White R, Skolnick M: Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science 1987, 236:1100-1102
4. von Deimling A, Krone W, Menon AG: Neurofibromatosis type 1: pathology, clinical features and molecular genetics. Brain Pathol 1995, 5:153-162
5. Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL, Brownstein BH, Collins FS: Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 1990, 249:181-186
6. Li Y, Bollag G, Clark R, Stevens J, Conroy L, Fults D, Ward K, Friedman E, Samowitz W, Robertson M, Bradley P, McCormick F, White R, Cawthon R: Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 1992, 69:275-281
7. The I, Murthy AE, Hannigan GE, Jacoby LB, Menon AG, Gusella JF, Bernards A: Neurofibromatosis type 1 gene mutations in neuroblastoma. Nature Genet 1993, 3:62-66
8. Andersen LB, Fountain JW, Gutmann DH, Tarlé SA, Glover TW, Dracopoli NC, Housman DE, Collins FS: Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines. Nature Genet 1993, 3:118-121
9. Johnson MR, Look AT, DeClue JE, Valentine MB, Lowy DR: Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulation of GTP. Ras. Proc Natl Acad Sci USA 1993, 90:5539-5543
10. Gutmann DH, Giordano MJ, Mahadeo DK, Lau N, Silbergeld D, Guha A: Increased neurofibromatosis 1 gene expression in astrocytic tumors: positive regulation by p21-ras. Oncogene 1996, 12:2121-2127
11. Hermonen J, Hirvonen O, Ylä-Outinen H, Lakkakorpi J, Björkstrand A-S, Laurikainen L, Kallioinen M, Oikarinen A, Peltonen S, Peltonen J: Neurofibromin: expression by normal human keratinocytes in vivo and in vitro and in epidermal malignancies. Lab Invest 1995, 73:221-228
12. Gutmann DH, Geist RT, Rose K, Wallin G, Moley JF: Loss of neurofibromatosis type 1 (NF1) gene expression in pheochromocytomas from patients without NF1. Genes Chromosomes & Cancer 1995, 13:104-109
13. Sundaram V, Lee JH, Harwalkar JA, Stein DJ, Roudebush M, Stacey DW, Golubic M: Reduced expression of neurofibromin in human meningiomas. Br J Cancer 1997, 76:747-56
14. Peltonen J, Karvonen S-L, Ylä-Outinen H, Hirvonen O, Karvonen J: Lesional psoriatic epidermis displays reduced neurofibromin immunoreactivity. J Invest Dermatol 105:664-667
15. Golubic M, Roudebush M, Dobrowolski S, Wolfman A, Stacey DW: Catalytic properties, tissue and intracellular distribution of neurofibromin. Oncogene 1992, 7:2151-2159
16. Gutmann DH, Geist RT, Wright DE, Snider WD: Expression of the neurofibromatosis 1 (NF1) isoforms in developing and adult rat tissues. Cell Growth Differ 1995, 6:315-323
17. Uchida T, Wada C, Ishida H, Egawa S, Ao T, Yokoyma E, Koshiba K: Infrequent involvement of mutations on neurofibromatosis type 1, H-ras, K-ras and N-ras in urothelial tumors. Urol Int 1995, 55:63-67
18. Bollag G, McCormick F: NF is enough of GAP. Nature 1992, 356:663-664
19. Gregory PE, Gutmann DH, Mitchell A, Park S, Boguski M, Jacks T, Wood DL, Jove R, Collins FS: Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules. Somat Cell Mol Genet 1993, 19:265-274
20. Xu H, Gutmann DH: Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules. Brain Res 1997, 759:149-152
21. Andersen LB, Ballester R, Marchuk DA, Chang E, Gutmann DH, Saulino AM, Camonis J, Wigler M, Collins FS: A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Moll Cell Biol 1993, 13:487-495
22. Gutmann DH, Geist RT, Rose K, Wright DE: Expression of two new protein isoforms of the neurofibromatosis type 1 gene product, neurofibromin, in muscle tissues. Dev Dyn 1995, 202:302-311
23. Furth ME, Aldrich TH, Cordon-Gardo C: Expression of ras protooncogene proteins in normal human tissues. Oncogene 1987, 1:47-58
24. Denhardt DT: Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammal cell: the potential for multiplex signaling. Biochem J 1996, 318:729-747
25. Marshall MS: Ras target proteins in eukaryotic cells. FASEB J 1995, 9:1311-1318
26. Barbacid M: ras genes. Annu Rev Biochem 1987, 56:779-827
27. Quilliam LA, Khosravi-Far R, Huff SY, Der CJ: Guanine nucleotide exchange factors: activators of the Ras superfamily of proteins. Bioessays 1995, 17:395-404
28. Bokoch GM, Der CJ: Emerging concepts in the Ras superfamily of GTP-binding proteins. FASEB J 1993, 7:750-759
29. Boguski MS, McCormick F: Proteins regulating Ras and its relatives. Nature 1993, 366:643-654
30. Cancer Society of Finland: Cancer incidence in Finland 1995: cancer statistics of the National Research and Development Centre for Welfare and Health. Cancer Society of Finland publication 58. Helsinki, Finland Finnish Cancer Registry, 1997
31. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J (editors): Cancer Incidence in Five Continents, vol 6. Lyon, France, International Agency for Research on Cancer and International Association of Cancer Registries (World Health Organization), 1992, pp 976-977
32. Cordon-Cardo C, Sheinfeld J: Molecular and immunopathology studies of oncogenes and tumor-suppressor genes in bladder cancer. World J Urol 1997, 15:112-119
33. Sidransky D, von Eschenbach A, Tsai YC, Jones P, Summerhayes I, Marshall F, Paul M, Green P, Hamilton SR, Frost P, Vogelstein B: Identification of p53 gene mutations in bladder cancer and urine samples. Science 1991, 252:706-709
34. Spruck CH III, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmütte C, Yang AS, Cote R, Dubeau L, Nichols PW, Hermann GG, Steven K, Horn T, Skinner DG, Jones PA: Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 1994, 54:784-788
35. Mostofi FK, Sobin LH, Torloni H: Histological typing of urinary bladder tumours. Geneva, World Health Organization, 1973, pp 15-34
36. Nishi T, Lee PSY, Oka K, Lewin VA, Tanase S, Morino Y, Saya H: Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation. Oncogene 1991, 6:1555-1559
37. Sandberg M, Vuorio E: Localization of types I, II, and III collagen mRNAs in developing human skeletal tissues by Northern and in situ hybridization. J Cell Biol 1987, 104:1077-1084
38. Ylä-Herttuala S, Roosenfeld ME, Parthasarathy S, Glass CK, Sigal E, Witztum JL, Steinberg D: Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci USA 1990, 87:6959-6963
39. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979, 18:5294-5299
40. Ylä-Outinen H, Aaltonen V, Björkstrand A-S, Hirvonen O, Lakkakorpi J, Vähä-Kreula M, Laato M, Peltonen J: Up-regulation of tumor suppressor protein neurofibromin in normal human wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor β1 (TGFβ1) elicited increase in neurofibromin mRNA steady-state levels in dermal fibroblasts. J Invest Dermatol 1998, 110:232-237
41. Hoffmeyer S, Assum G, Griesser J, Kaufmann D, Nurnberg P, Krone W: An unequal allelic expression of the neurofibromin gene in neurofibromatosis type 1. Hum Mol Genet 1995, 4:1262-1272
42. Boyer MJ, Gutmann DH, Collins FS, Bar-Sagi D: Crosslinking of the surface immunoglobulin receptor in B lymphocytes induces a redistribution of neurofibromin but not p120-GAP. Oncogene 1994, 9:49-357
43. Norton KK, Xu J, Gutmann DH: Expression of the neurofibromatosis I gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle. Neurobiol Dis 1995, 2:13-21
44. Bos JL: ras oncogenes in human cancer: a review. Cancer Res 1989, 49:4682-4689
45. Fujita J, Srivastava SK, Kraus MH, Rhim JS, Tronick SR, Aaronson SA: Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors. Proc Natl Acad Sci USA 1985, 82:3849-3853
46. Chaturvedi V, Li L, Hodges S, Johnston D, Ro JY, Logothetis C, von Eschenbach AC, Batsakis JG, Czerniak B: Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia. Oncogene 1997, 14:2059-2070
47. Burchill SA, Berry PA, Lewis IJ: Changing expression of GTPase activating proteins with differentiation in neuroblastoma. J Neurol Sci 1994, 126:126-132
48. Johnson MR, DeClue JE, Felzmann S, Vass WC, Xu G, White R, Lowy DR: Neurofibromin can inhibit Ras-dependent growth by a mechanism independent of its GTPase-accelerating function. Mol Cell Biol 1994, 14:641-645
49. Jimbo H, Totsuka Y, Mashimo P, Umeyama T, Uehara H, Shinozak T: Bladder tumor associated with von Recklinghausen's neurofibromatosis: a case report. Hinyokika-Kiyo 1995, 41:61-64
50. Yonemura S, Okuno T, Yamada Y, Uchida K, Arima K, Yanagawa M, Kawamura J: Bladder cancer associated with von Recklinghausen's disease: a case report. Hinyokika-Kiyo 1997, 43:585-588
51. Harbour JW, Lai SL, Whang-Peng J, Gazdar AF, Minna JD, Kaye FJ: Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 1988, 241:353-357
52. Yokota J, Akiyama T, Fung YK, Benedict WF, Namba Y, Hanaoka N, Wada M, Terasaki T, Shimosato Y, Sugimura T, Terada M: Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. Oncogene 1988, 3:471-475
53. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, Lee EY: Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science 1987, 235:1394-1399
54. Cordon-Cardo C, Wartinger D, Petrylak D, Dalbagni G, Fair WR, Fuks Z, Reuter VE: Altered expression of the retinoblastoma gene is a prognostic indicator in bladder cancer. J Natl Cancer Inst 1992, 84:1251-1256
55. Logothetis CJ, Xu HJ, Ro JY, Hu SX, Sahin A, Ordonez N, Benedict WF: Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst 1992, 84:1256-1261